Intra-cellular therapies to present at the morgan stanley 21st annual global healthcare conference

New york, sept. 05, 2023 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that it will present at the morgan stanley 21st annual global healthcare conference on tuesday, september 12, 2023 at 12:55 p.m. et.
ITCI Ratings Summary
ITCI Quant Ranking